Article Abstract

James D. Brooks: prostate cancer screening awaits optimization to reduce inappropriate treatment

Authors: Brad Li

Abstract

Prostate cancer, defined by the abnormal growth of cells, is a widely variable disease. According to the statistics of Prostate Cancer Free Foundation, prostate cancer is other than skin cancer the most common malignancy diagnosed in men with up to 1.1 million newly diagnosed cases each year (1).